BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1153 related articles for article (PubMed ID: 19528407)

  • 1. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
    Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.
    Porceddu SV; Campbell B; Rischin D; Corry J; Weih L; Guerrieri M; Grossi M; Peters LJ
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):365-73. PubMed ID: 15380568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous radio- and chemotherapy for squamous cell carcinoma of the head and neck in daily clinical practice: 5 years experience in a University Hospital.
    Langenberg M; Terhaard CH; Hordijk GJ; Es RJ; Voest EE; Graeff A
    Clin Otolaryngol Allied Sci; 2004 Dec; 29(6):729-34. PubMed ID: 15533169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined-modality treatment for advanced oral tongue squamous cell carcinoma.
    Fan KH; Lin CY; Kang CJ; Huang SF; Wang HM; Chen EY; Chen IH; Liao CT; Cheng AJ; Chang JT
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):453-61. PubMed ID: 17236967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
    Fortin A; Caouette R; Wang CS; Vigneault E
    Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
    Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
    J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective vs modified radical neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongue.
    Schiff BA; Roberts DB; El-Naggar A; Garden AS; Myers JN
    Arch Otolaryngol Head Neck Surg; 2005 Oct; 131(10):874-8. PubMed ID: 16230589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement.
    Racadot S; Mercier M; Dussart S; Dessard-Diana B; Bensadoun RJ; Martin M; Malaurie E; Favrel V; Housset M; Durdux C; Journel C; Calais G; Huet J; Pillet G; Hennequin C; Haddad E; Diana C; Blaska-Jaulerry B; Henry-Amar M; Géhanno P; Baillet F; Mazeron JJ
    Radiother Oncol; 2008 May; 87(2):164-72. PubMed ID: 18222010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data.
    Lang K; Menzin J; Earle CC; Jacobson J; Hsu MA
    Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1269-75. PubMed ID: 15545580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
    Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ
    Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.
    Nuyts S; Dirix P; Clement PM; Poorten VV; Delaere P; Schoenaers J; Hermans R; Van den Bogaert W
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1088-95. PubMed ID: 18707823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials.
    Rewari AN; Haffty BG; Wilson LD; Son YH; Joe JK; Ross DA; Papac RJ; Sasaki CT; Fischer JJ
    Cancer J; 2006; 12(2):123-9. PubMed ID: 16630403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of treatments for head and neck squamous cell carcinomas].
    Tsukuda M
    Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():85-96. PubMed ID: 10410663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative complications after en bloc salvage surgery for head and neck cancer.
    Agra IM; Carvalho AL; Pontes E; Campos OD; Ulbrich FS; Magrin J; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1317-21. PubMed ID: 14676158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer.
    Chen AM; Li BQ; Lau DH; Farwell DG; Luu Q; Stuart K; Newman K; Purdy JA; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1026-32. PubMed ID: 20231073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma.
    Taguchi T; Ikeda Y; Mikami Y; Kawai S; Arai Y; Mochimatsu I; Tsukuda M
    Anticancer Res; 2003; 23(1B):713-7. PubMed ID: 12680172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
    Law A; Kennedy T; Pellitteri P; Wood C; Christie D; Yumen O
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1361-8. PubMed ID: 17869022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.
    Givens DJ; Karnell LH; Gupta AK; Clamon GH; Pagedar NA; Chang KE; Van Daele DJ; Funk GF
    Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1209-17. PubMed ID: 20026818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.